QT Vascular to hold EGM on June 2 on proposed sale of catheter product
QT Vascular will conduct an extraordinary general meeting on June 2 to seek shareholder approval to sell its non-drug coated balloon catheter product to Medtronic Inc.
The company, which specialises in developing catheter products, said on May 12 that it had agreed to a deal that gives Medtronic the option to buy the Chocolate PTA balloon catheter product for US$28 million. The option is exercisable within 90 days upon the achievement of certain milestones.
Concurrent with the deal, Medtronic will also be extending a US$1.25 million 8 per cent facility to QT Vascular for up to three years.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
S&P slashes Boeing credit outlook as rating hovers above junk status
Honda to spend US$11 billion on EV strategy in Canada
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
Mapletree Industrial Trust Q4 DPU rises 0.9% to S$0.0336
Nasdaq’s profit falls as shaky economy keeps IPO revival elusive
iFast Q1 net profit surges on ePension unit performance